These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10532947)

  • 1. Identification and characterization of a new growth hormone-releasing peptide receptor in the heart.
    Bodart V; Bouchard JF; McNicoll N; Escher E; Carrière P; Ghigo E; Sejlitz T; Sirois MG; Lamontagne D; Ong H
    Circ Res; 1999 Oct; 85(9):796-802. PubMed ID: 10532947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart.
    Bodart V; Febbraio M; Demers A; McNicoll N; Pohankova P; Perreault A; Sejlitz T; Escher E; Silverstein RL; Lamontagne D; Ong H
    Circ Res; 2002 May; 90(8):844-9. PubMed ID: 11988484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific receptors for synthetic GH secretagogues in the human brain and pituitary gland.
    Muccioli G; Ghè C; Ghigo MC; Papotti M; Arvat E; Boghen MF; Nilsson MH; Deghenghi R; Ong H; Ghigo E
    J Endocrinol; 1998 Apr; 157(1):99-106. PubMed ID: 9614363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone-releasing peptides and the cardiovascular system.
    Muccioli G; Broglio F; Valetto MR; Ghè C; Catapano F; Graziani A; Papotti M; Bisi G; Deghenghi R; Ghigo E
    Ann Endocrinol (Paris); 2000 Feb; 61(1):27-31. PubMed ID: 10790589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a pituitary growth hormone-releasing peptide (GHRP) receptor subtype by photoaffinity labeling.
    Ong H; McNicoll N; Escher E; Collu R; Deghenghi R; Locatelli V; Ghigo E; Muccioli G; Boghen M; Nilsson M
    Endocrinology; 1998 Jan; 139(1):432-5. PubMed ID: 9421445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding sites for growth hormone-releasing peptide.
    Ong H; Bodart V; McNicoll N; Lamontagne D; Bouchard JF
    Growth Horm IGF Res; 1998 Apr; 8 Suppl B():137-40. PubMed ID: 10990149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural (ghrelin) and synthetic (hexarelin) GH secretagogues stimulate H9c2 cardiomyocyte cell proliferation.
    Pettersson I; Muccioli G; Granata R; Deghenghi R; Ghigo E; Ohlsson C; Isgaard J
    J Endocrinol; 2002 Oct; 175(1):201-9. PubMed ID: 12379504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protectant activity of hexarelin or growth hormone against postischemic ventricular dysfunction in hearts from aged rats.
    Rossoni G; De Gennaro Colonna V; Bernareggi M; Polvani GL; Müller EE; Berti F
    J Cardiovasc Pharmacol; 1998 Aug; 32(2):260-5. PubMed ID: 9700988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines.
    Cassoni P; Papotti M; Ghè C; Catapano F; Sapino A; Graziani A; Deghenghi R; Reissmann T; Ghigo E; Muccioli G
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1738-45. PubMed ID: 11297611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific binding sites for synthetic growth hormone secretagogues in non-tumoral and neoplastic human thyroid tissue.
    Cassoni P; Papotti M; Catapano F; Ghè C; Deghenghi R; Ghigo E; Muccioli G
    J Endocrinol; 2000 Apr; 165(1):139-46. PubMed ID: 10750044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine, metabolic and cardioprotective effects of hexarelin in obese Zucker rats.
    De Gennaro-Colonna V; Rossoni G; Cocchi D; Rigamonti AE; Berti F; Muller EE
    J Endocrinol; 2000 Sep; 166(3):529-36. PubMed ID: 10974647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac ischemia and impairment of vascular endothelium function in hearts from growth hormone-deficient rats: protection by hexarelin.
    De Gennaro Colonna V; Rossoni G; Bernareggi M; Müller EE; Berti F
    Eur J Pharmacol; 1997 Sep; 334(2-3):201-7. PubMed ID: 9369349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hexarelin, a growth hormone secretagogue, protects the isolated rat heart from ventricular dysfunction produced by exposure to calcium-free medium.
    Rossoni G; Locatelli V; Gennaro Colonna Vd ; Müller EE; Berti F
    Pharmacol Res; 2000 Aug; 42(2):129-36. PubMed ID: 10887041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective lack of growth hormone (GH) response to the GH-releasing peptide hexarelin in patients with GH-releasing hormone receptor deficiency.
    Maheshwari HG; Rahim A; Shalet SM; Baumann G
    J Clin Endocrinol Metab; 1999 Mar; 84(3):956-9. PubMed ID: 10084578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone-independent cardioprotective effects of hexarelin in the rat.
    Locatelli V; Rossoni G; Schweiger F; Torsello A; De Gennaro Colonna V; Bernareggi M; Deghenghi R; Müller EE; Berti F
    Endocrinology; 1999 Sep; 140(9):4024-31. PubMed ID: 10465272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortistatin, but not somatostatin, binds to growth hormone secretagogue (GHS) receptors of human pituitary gland.
    Deghenghi R; Papotti M; Ghigo E; Muccioli G
    J Endocrinol Invest; 2001 Jan; 24(1):RC1-3. PubMed ID: 11227737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Growth Hormone Secretagogue Hexarelin Protects Rat Cardiomyocytes From in vivo Ischemia/Reperfusion Injury Through Interleukin-1 Signaling Pathway.
    Huang J; Li Y; Zhang J; Liu Y; Lu Q
    Int Heart J; 2017 Apr; 58(2):257-263. PubMed ID: 28321024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of acute hexarelin administration on cardiac performance in patients with coronary artery disease during by-pass surgery.
    Broglio F; Guarracino F; Benso A; Gottero C; Prodam F; Granata R; Avogadri E; Muccioli G; Deghenghi R; Ghigo E
    Eur J Pharmacol; 2002 Jul; 448(2-3):193-200. PubMed ID: 12144941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone secretagogue binding sites in peripheral human tissues.
    Papotti M; Ghè C; Cassoni P; Catapano F; Deghenghi R; Ghigo E; Muccioli G
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3803-7. PubMed ID: 11061542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is GHRH receptor essential to GHRP-2-induced GH secretion in primary cultured rat pituitary cells?
    Roh SG; Chen C; Choi KC; Shrestha Y; Sasaki S
    Endocrinology; 2002 May; 143(5):1964-7. PubMed ID: 11956179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.